Paediatric IOS and BMI Data for SCD and Asthma

Columns

• Group: Indicates the study cohort: children with sickle cell disease (C-SCD) or African-American children with asthma (C-Asthma).
• Subject ID: A unique identifier assigned to each participant to differentiate individuals.
• Observation number: The sequential number of the measurement for a specific subject, reflecting the longitudinal nature of the study.
• Hydroxyurea: Boolean value indicating if the subject with sickle cell disease received hydroxyurea treatment.
• Asthma: Boolean value indicating if the subject has a diagnosis of asthma.
• ICS: Indicates whether the subject is using inhaled corticosteroids.
• LABA: Indicates whether the subject is using a long-acting beta-agonist.
• Gender: Specifies the gender of the subject (Male or Female).
• Age: The age of the subject in months at the time of observation.
• Height: The subject's height, measured in centimetres.
• Weight (Kg): The subject's weight, measured in kilograms.
• BMI: Calculated Body Mass Index (weight in kg divided by height in metres squared).
• R5Hz_PP: Estimate of airway resistance at 5 Hz obtained via impulse oscillometry.
• R20Hz_PP: Estimate of airway resistance at 20 Hz obtained via impulse oscillometry.
• X5Hz_PP: Estimate of airway reactance at 5 Hz (measure of elasticity/stiffness) via IOS.
• Fres_PP: Estimate of resonant frequency (where reactance transitions from positive to negative) via IOS.

Distribution

• Format: CSV
• Size: 219 valid observations across 16 columns.
• Demographics: The dataset comprises approximately 74% subjects with Sickle Cell Disease (C-SCD) and 26% with Asthma (C-Asthma).
• Gender Balance: Approximately 44% Male, 40% Female, with remaining entries categorised as Other/Unspecified.
• Statistical Range: Age ranges from 50 to 239 months; BMI ranges from approximately 13.7 to 48.1.

Usage

• Paediatric Pulmonology Research: Investigating the correlation between BMI and lung function parameters (resistance and reactance) in children.
• Comparative Disease Analysis: Comparing respiratory mechanics between children with sickle cell disease and those with asthma.
• Pharmacological Impact Studies: Assessing the influence of treatments like hydroxyurea, ICS, and LABA on IOS measures.
• Longitudinal Health Tracking: Modelling changes in respiratory function over time within specific patient cohorts.

Coverage

• Time Range: The study encompasses data collected from 2015 to 2020.
• Demographic Scope: Children with sickle cell disease and African-American children with asthma.
• Geographic Note: While specific location data is not detailed, the demographic profile implies a specific study setting relevant to these populations.

License

Who Can Use It

• Medical Researchers and Biostatisticians
• Paediatricians and Pulmonologists
• Public Health Analysts
• Data Scientists specialising in Healthcare Informatics

Dataset Name Suggestions

• Paediatric IOS and BMI Data for SCD and Asthma
• Sickle Cell and Asthma Respiratory Mechanics Dataset
• Longitudinal Airway Resistance and Reactance Data (2015-2020)
• BMI Impact on Respiratory Function in Children

Attributes